Soleus Capital Management, L.P. Charles River Laboratories International, Inc. Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $22.1 Million - $24.7 Million	-113,432 Reduced 54.15%	96,064 $18.8 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $9.81 Million - $11.2 Million	53,400 Added 34.21%	209,496 $44 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $10.4 Million - $14.1 Million	54,246 Added 53.26%	156,096 $31.5 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $5.37 Million - $6.81 Million	-27,250 Reduced 21.11%	101,850 $22.2 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $23.6 Million - $32.3 Million	129,100 New	129,100 $25.4 Million

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.64B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.